Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.8mm RC, SLActive 8mm, TiZr, NTP: medical device reports filed with FDA

5,545 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

5,545
device reports naming the brand
0% of all MAUDE reports · about 812 a year
730
reports, 12 months to August 2026
879 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 5,545 reports that name the brand "BL, ? 4.8mm RC, SLActive 8mm, TiZr, NTP" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

730 reports arrived in the 12 months to August 2026, down 17% from 879 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (63.6%), loss of osseointegration (28.2%) and difficult to insert (0.9%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

087174Sep 2021: 58Oct 2021: 70Nov 2021: 99Dec 2021: 452022Jan 2022: 78Feb 2022: 37Mar 2022: 54Apr 2022: 70May 2022: 51Jun 2022: 59Jul 2022: 62Aug 2022: 83Sep 2022: 80Oct 2022: 80Nov 2022: 88Dec 2022: 1292023Jan 2023: 40Feb 2023: 50Mar 2023: 52Apr 2023: 82May 2023: 82Jun 2023: 71Jul 2023: 67Aug 2023: 69Sep 2023: 62Oct 2023: 85Nov 2023: 77Dec 2023: 852024Jan 2024: 77Feb 2024: 67Mar 2024: 79Apr 2024: 85May 2024: 61Jun 2024: 60Jul 2024: 75Aug 2024: 59Sep 2024: 97Oct 2024: 75Nov 2024: 78Dec 2024: 872025Jan 2025: 46Feb 2025: 53Mar 2025: 78Apr 2025: 33May 2025: 0Jun 2025: 174Jul 2025: 75Aug 2025: 83Sep 2025: 61Oct 2025: 66Nov 2025: 65Dec 2025: 582026Jan 2026: 44Feb 2026: 64Mar 2026: 54Apr 2026: 58May 2026: 57Jun 2026: 64Jul 2026: 62Aug 2026: 77

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04509002019: 42420192020: 55020202021: 70620212022: 87120222023: 82220232024: 90020242025: 79220252026: 4802026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,545
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report78.5%4,355
Voluntary report0%0
User facility report0%0
Distributor report21.5%1,190
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate3,52763.6%62.8%
Loss of osseointegration1,56428.2%22.4%
Difficult to insertthe device was hard to insert490.9%0.4%
Fracturea broken bone190.3%1.6%
Separation failure80.1%0.1%
Unstable50.1%0%
Therapeutic or diagnostic output failure40.1%0%
Positioning problem30.1%0.1%
Unintended movement30.1%0%
Difficult to removethe device was hard to remove20%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,66530%
Painpain, site not specified1,00218.1%
Tissue damage61511.1%
Inflammationinflammation3927.1%
Hemorrhage/blood loss/bleeding2755%
Swelling/ edema1873.4%
Hyperresponsive to stimuli1071.9%
Fistula1051.9%
Abscessa collection of pus911.6%
Failure of implant581%
Sinus perforation450.8%
Hypersensitivity/allergic reaction390.7%
Numbnessnumbness340.6%
Inadequate osseointegration250.5%
Swellingswelling200.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.8mm RC, SLActive 8mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports5,5453,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer78.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.8mm RC, SLActive 8mm, TiZr, NTP reports

How many FDA reports name BL, ? 4.8mm RC, SLActive 8mm, TiZr, NTP?

5,545 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 730 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (63.6%), loss of osseointegration (28.2%), difficult to insert (0.9%), fracture (0.3%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (78.5%) and distributor reports (21.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.8mm RC, SLActive 8mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.